Professor Andrew Tutt is a consultant clinical oncologist the Guy's Hospital Breast Unit and is Professor in Oncology at King's College London. He trained in clinical oncology at the Royal Marsden Hospital London and in breast cancer research at London's Institute of Cancer Research, where he gained his PhD in cancer biology. Professor Tutt focuses his clinical practice exclusively on breast oncology and its systemic and radiation therapies. He has a particular research interest in 'triple nega...
Professor Andrew Tutt is a consultant clinical oncologist the Guy's Hospital Breast Unit and is Professor in Oncology at King's College London. He trained in clinical oncology at the Royal Marsden Hospital London and in breast cancer research at London's Institute of Cancer Research, where he gained his PhD in cancer biology.
Professor Tutt focuses his clinical practice exclusively on breast oncology and its systemic and radiation therapies. He has a particular research interest in 'triple negative' and BRCA1 and BRCA2 associated breast cancers where he leads a number of international clinical trials of drug therapies and is the director of a research program focusing on these areas.
Professor Tutt has published and presented a large number of breast cancer research papers and is an invited speaker and session chair at major European and North American Cancer Medicine conferences. He is a member of the St Gallen International Breast Cancer Consensus Panel that develops international breast cancer treatment guidelines. He is a member of a UK team testing new techniques in breast radiotherapy and has written review articles on this topic in international journals.
Professor Tutt offers treatment at the clinical oncology departments in the Integrated Cancer Centre at Guy's and St Thomas's Hospitals near London Bridge and Waterloo Stations and has private practice privileges at HCA's London Bridge Hospital and the Harley Street Clinic Cancer Centre. He can offer the latest 3D radiotherapy planning and IMRT techniques as well as advice on a range of systemic therapy treatments recommended by international guidelines.